Clinical Validation of a PCR Assay for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer: Retrospective Testing of Specimens from the EURTAC Trial

The EURTAC trial demonstrated that the tyrosine kinase inhibitor (TKI) erlotinib was superior to chemotherapy as first-line therapy for advanced non-small cell lung cancers (NSCLC) that harbor EGFR activating mutations in a predominantly Caucasian population. Based on EURTAC and several Asian trials...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Benlloch, Susana, Botero, Maria Luisa, Beltran-Alamillo, Jordi, Mayo, Clara, Gimenez-Capitán, Ana, de Aguirre, Itziar, Queralt, Cristina, Ramirez, Jose Luis, Cajal, Santiago Ramón y., Klughammer, Barbara, Schlegel, Mariette, Bordogna, Walter, Chen, David, Zhang, Guili, Kovach, Barbara, Shieh, Felice, Palma, John F., Wu, Lin, Lawrence, H. Jeffrey, Taron, Miquel
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2014
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934888/
https://ncbi.nlm.nih.gov/pubmed/24586842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0089518
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים